CELSCI Corporation (CVM)

Name: CELSCI Corporation Financial Statements
Creator: Quarter Results

Healthcare | Biotechnology

Latest reporting period: 2025-03-31

Latest Quarter

2025-03-31

Revenue

$0.0

Net Income

$0.0

Operating Margin

N/A

Free Cash Flow

-$17.2B

Debt / Assets

43.3%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for CELSCI Corporation (CVM).
Income Statement (Quarterly)	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Revenue	0	0	0	0
Cost of Revenue	0	0	991,580	983,208
Gross Profit	0	0	-991,580	-983,208
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	0	2,463,355	1,643,157	1,967,075
Operating Expenses	0	5,898,226	5,128,824	6,670,235
Operating Income	0	-6,893,418	-6,120,404	-6,670,235
Interest Expense	0	170,103	174,571	190,705
Income Before Tax	0	-7,073,062	-6,109,492	-6,856,558
Income Tax Expense	0	0	-171,753	0
Net Income	0	-7,073,062	-6,109,492	-6,856,558
Per Share
EPS	-0.08	-0.11	-0.11	-0.14
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for CELSCI Corporation (CVM).
Income Statement (Annual)	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30
Revenue	0	0	0	0	0
Cost of Revenue	3,885,153	3,969,183	3,958,334	3,883,386	0
Gross Profit	-3,885,153	-3,969,183	-3,958,334	-3,883,386	0
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	5,037,606	4,221,840	9,004,578	10,707,447	13,085,232
Operating Expenses	20,924,583	22,383,291	31,476,074	36,062,793	36,194,129
Operating Income	-24,809,736	-26,352,474	-31,476,074	-36,062,793	-36,194,129
Interest Expense	648,944	745,673	675,416	1,081,034	-1,149,288
Income Before Tax	-25,411,055	-26,920,465	-32,194,302	-36,700,681	-36,361,109
Income Tax Expense	0	0	0	1,567,010	0
Net Income	-25,411,055	-26,920,465	-32,365,855	-38,267,691	-36,361,109
Per Share
EPS	-6.27	-13.50	-0.73	-0.89	-0.90
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for CELSCI Corporation (CVM).
Balance Sheet (Quarterly)	2025-09-30	2024-09-30	2023-09-30	2022-09-30
Assets
Cash and Cash Equivalents	10,953,460,000	4,738,173	4,145,735	22,672,138
Short Term Investments	0	3,500	4	0
Net Receivables	0	0	0	-2,001,715
Inventory	0	1,019,908	2,248,072	2,001,715
Total Current Assets	11,596,128,000	6,055,678	6,918,420	25,435,916
Property Plant Equipment	12,902,261,000	16,976,054	21,018,356	24,711,290
Goodwill and Intangibles	119,856	165,492	197,704	212,201
Total Assets	28,155,748,000	26,991,766	30,528,250	50,523,706
Liabilities
Account Payables	1,061,351	1,448,467	2,009,786	1,618,290
Short Term Debt	2,440,787,000	4,475,928	1,969,235	1,731,481
Total Current Liabilities	5,130,546,000	4,615,779	5,585,846	4,663,751
Long Term Debt	6,950,060,117	9,383,904	11,602,514	13,571,748
Total Liabilities	12,198,663,000	14,124,683	17,313,360	18,360,499
Shareholders Equity
Retained Earnings	-539,422,916	-514,011,861	-487,091,396	-454,897,093
Total Shareholders Equity	15,957,085	12,867,083	13,214,890	32,163,207

Balance sheet annual history for CELSCI Corporation (CVM).
Balance Sheet (Annual)	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30
Assets
Cash and Cash Equivalents	10,953,460,000	4,738,173	4,145,735	22,672,138	36,060,148
Short Term Investments	0	3,500	4	0	0
Net Receivables	0	0	0	-2,001,715	54,922
Inventory	0	1,019,908	2,248,072	2,001,715	0
Total Current Assets	11,596,128,000	6,055,678	6,918,420	25,435,916	45,271,521
Property Plant Equipment	12,902,261,000	16,976,054	21,018,356	24,711,290	26,355,483
Goodwill and Intangibles	119,856	165,492	197,704	212,201	0
Total Assets	28,155,748,000	26,991,766	30,528,250	50,523,706	75,869,965
Liabilities
Account Payables	1,061,351	1,448,467	2,009,786	1,618,290	1,675,813
Short Term Debt	2,440,787,000	4,475,928	1,969,235	1,731,481	1,397,330
Total Current Liabilities	5,130,546,000	4,615,779	5,585,846	4,663,751	3,937,067
Long Term Debt	6,950,060,117	9,383,904	11,602,514	13,571,748	0
Total Liabilities	12,198,663,000	14,124,683	17,313,360	18,360,499	19,335,739
Shareholders Equity
Retained Earnings	-539,422,916	-514,011,861	-487,091,396	-454,897,093	-418,196,412
Total Shareholders Equity	15,957,085	12,867,083	13,214,890	32,163,207	56,534,226

Cash flow quarterly history for CELSCI Corporation (CVM).
Cash Flow Statement (Quarterly)	2025-09-30	2024-09-30	2023-09-30	2022-09-30
Operating Activities
Net Income	-25,411,055,000	-26,920,465	-32,194,303	-36,700,681
Depreciation & Amortization	3,885,153,000	3,969,183	3,958,334	3,828,917
Stock Based Compensation	1,910,997,000	4,270,180	7,149,564	11,612,975
Change in Working Capital	1,162,415	-1,212,192	-1,777,448	2,537,721
Operating Cash Flow	-17,119,737,000	-18,811,206	-22,848,561	-18,240,951
Investing Activities
Capital Expenditure	-38,109,000	-94,875	-372,262	-660,633
Investments	-38,109,000	-94,875	-372,262	-660,633
Investing Cash Flow	-38,109,000	-108,086	-372,262	5,491,367
Financing Activities
Debt Repayment	-2,011,183	-1,773,377	-1,560	-1,386,495
Common Stock Issued/Repurchased	25,164,321	23,655,620	6,254,875	-38,385
Dividends Paid	0	0	0	0
Financing Cash Flow	23,373,133,000	19,511,730	4,694	-638,426
Summary
Free Cash Flow	-17,157,846,000	-18,906,081	-23,220,823	-18,901,584
Net Change in Cash	6,215,287,000	592,438	-18,526,403	-13,388,010

Cash flow annual history for CELSCI Corporation (CVM).
Cash Flow Statement (Annual)	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30
Operating Activities
Net Income	-25,411,055,000	-26,920,465	-32,194,303	-36,700,681	-36,361,109
Depreciation & Amortization	3,885,153,000	3,969,183	3,958,334	3,828,917	2,231,108
Stock Based Compensation	1,910,997,000	4,270,180	7,149,564	11,612,975	13,685,046
Change in Working Capital	1,162,415	-1,212,192	-1,777,448	2,537,721	-483,474
Operating Cash Flow	-17,119,737,000	-18,811,206	-22,848,561	-18,240,951	-18,787,016
Investing Activities
Capital Expenditure	-38,109,000	-94,875	-372,262	-660,633	-9,016,329
Investments	-38,109,000	-94,875	-372,262	-660,633	-9,016,329
Investing Cash Flow	-38,109,000	-108,086	-372,262	5,491,367	-15,184,734
Financing Activities
Debt Repayment	-2,011,183	-1,773,377	-1,560	-1,386,495	-1,079,392
Common Stock Issued/Repurchased	25,164,321	23,655,620	6,254,875	-38,385	47,363,426
Dividends Paid	0	0	0	0	0
Financing Cash Flow	23,373,133,000	19,511,730	4,694	-638,426	54,522,989
Summary
Free Cash Flow	-17,157,846,000	-18,906,081	-23,220,823	-18,901,584	-27,803,345
Net Change in Cash	6,215,287,000	592,438	-18,526,403	-13,388,010	20,551,239